Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

AVEN antibody (N-Term)

AVEN Reactivity: Human WB Host: Rabbit Polyclonal RB41905 unconjugated
Catalog No. ABIN1881095
  • Target See all AVEN Antibodies
    AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
    Binding Specificity
    • 15
    • 12
    • 7
    • 6
    • 1
    • 1
    • 1
    • 1
    AA 78-106, N-Term
    Reactivity
    • 48
    • 13
    • 6
    • 3
    Human
    Host
    • 45
    • 3
    Rabbit
    Clonality
    • 44
    • 3
    Polyclonal
    Conjugate
    • 17
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    This AVEN antibody is un-conjugated
    Application
    • 40
    • 22
    • 13
    • 13
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This AVEN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 78-106 amino acids from the N-terminal region of human AVEN.
    Clone
    RB41905
    Isotype
    Ig Fraction
    Top Product
    Discover our top product AVEN Primary Antibody
  • Application Notes
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Expiry Date
    6 months
  • Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Ruaño, Thompson, Kane, Pullinger, Windemuth, Seip, Kocherla, Holford, Wu: "Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?" in: Pharmacogenomics, Vol. 11, Issue 7, pp. 959-71, (2010) (PubMed).

    Sugarbaker, Richards, Gordon, Dong, De Rienzo, Maulik, Glickman, Chirieac, Hartman, Taillon, Du, Bouffard, Kingsmore, Miller, Farmer, Jensen, Gullans, Bueno: "Transcriptome sequencing of malignant pleural mesothelioma tumors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 9, pp. 3521-6, (2008) (PubMed).

  • Target
    AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
    Alternative Name
    AVEN (AVEN Products)
    Synonyms
    AVEN antibody, pdcd12 antibody, aven antibody, wu:fc08c09 antibody, si:ch211-150c22.4 antibody, PDCD12 antibody, 1700013A01Rik antibody, 1700056A21Rik antibody, mAven-L antibody, mAven-S antibody, apoptosis and caspase activation inhibitor antibody, apoptosis, caspase activation inhibitor L homeolog antibody, apoptosis, caspase activation inhibitor antibody, Aven antibody, AVEN antibody, aven.L antibody, aven antibody
    Background
    AVEN protects against apoptosis mediated by Apaf-1.
    NCBI Accession
    NP_065104
    UniProt
    Q9NQS1
You are here:
Support